Company profile for Allogenica

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Allogenica is a biotechnology company specializing in the development of allogeneic CAR-T cell therapies for cancer treatment. Their platform utilizes hematopoietic stem cells to create "off-the-shelf" CAR-T cells, aiming to make T-cell therapies universally accessible by delivering treatments that are safer, more readily available to patients, and up to ten times less expensive to manufacture. While Allogenica is actively eng...
Allogenica is a biotechnology company specializing in the development of allogeneic CAR-T cell therapies for cancer treatment. Their platform utilizes hematopoietic stem cells to create "off-the-shelf" CAR-T cells, aiming to make T-cell therapies universally accessible by delivering treatments that are safer, more readily available to patients, and up to ten times less expensive to manufacture. While Allogenica is actively engaged in biotechnological research and development, it is not primarily a pharmaceutical manufacturing company.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
60 Av. Rockefeller, 69008 Lyon
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/03/19/3045186/0/en/Allogenica-Secures-2-5-Million-Grant-to-Advance-Universal-CAR-T-Therapy-and-Strengthen-France-s-Biotherapy-Leadership.html

GLOBENEWSWIRE
19 Mar 2025

https://www.globenewswire.com/news-release/2025/03/19/3045186/0/en/Allogenica-Secures-2-5-Million-Grant-to-Advance-Universal-CAR-T-Therapy-and-Strengthen-France-s-Biotherapy-Leadership.html

FDA
18 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty